Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Gaëtan Devos

12PUBLICATIONS
29CO-AUTHORS
Cancer diagnosisCell physiologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

Sort by Publication Date:
|Jan 09, 2026
Interreader agreement of intraprostatic prostate cancer detection, local extension and staging using [<sup>18</sup>F]PSMA-1007 PET and whole-mount radical prostatectomy specimens.

Niloefar Ahmadi Bidakhvidi, Elena Lara Jimenez, Hannes Leupe

|Nov 13, 2025
Relationship between [<sup>18</sup>F]PSMA-1007 PET parameters and biochemical recurrence-free survival in high-risk prostate cancer patients receiving neoadjuvant hormonal treatment.

Niloefar Ahmadi Bidakhvidi, Alexander Giesen, Gaëtan Devos

|Sep 13, 2024
Comparison of PSMA immunohistochemistry scoring systems to parametric [<sup>18</sup>F]PSMA-1007 PET/MRI in primary prostate cancer.

Niloefar Ahmadi Bidakhvidi, Thomas Gevaert, Maxim De Schepper

|Jul 08, 2024
Letter: A Prospective Randomized Trial of Neoadjuvant Chemohormonal Therapy vs Hormonal Therapy in Locally Advanced Prostate Cancer Treated by Radical Prostatectomy.

A Giesen, G Devos, W Everaerts

|Dec 26, 2022
Combining PSA and PET features to select candidates for salvage lymph node dissection in recurrent prostate cancer.

Carlo A Bravi, Axel Heidenreich, Nicola Fossati

|Sep 16, 2021
Neoadjuvant hormonal therapy before radical prostatectomy in high-risk prostate cancer.

Gaëtan Devos, Wout Devlies, Gert De Meerleer

Pageof 2

Frequent Collaborators

8 joint publications

Steven Joniau

4 joint publications

Alexander Giesen

4 joint publications

Wouter Everaerts

3 joint publications

Christophe M Deroose

3 joint publications

Wout Devlies

3 joint publications

Marcella Baldewijns

3 joint publications

Michel Koole

3 joint publications

Annouschka Laenen

3 joint publications

Karolien Goffin

3 joint publications

Niloefar Ahmadi Bidakhvidi

Frequent Collaborators

8 joint publications

Steven Joniau

4 joint publications

Alexander Giesen

4 joint publications

Wouter Everaerts

3 joint publications

Christophe M Deroose

Top Related Videos

A New Technique for Treating Low-risk Prostate Cancer&#8212;Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer&#8212;Super Active Surveillance

Published on : Nov 07, 2025

651
A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on : Mar 21, 2025

145
See more related videos

Top Related Videos

A New Technique for Treating Low-risk Prostate Cancer&#8212;Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer&#8212;Super Active Surveillance

Published on : Nov 07, 2025

651
A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on : Mar 21, 2025

145
See more related videos